West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.81% | -6.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.81% | -6.78% | |||
| Cost of Revenue | 5.69% | -1.91% | |||
| Gross Profit | 18.11% | -15.24% | |||
| SG&A Expenses | 9.12% | 3.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | -- | |||
| Total Operating Expenses | 6.53% | -1.33% | |||
| Operating Income | 24.32% | -25.09% | |||
| Income Before Tax | 42.23% | -31.76% | |||
| Income Tax Expenses | 25.31% | -34.51% | |||
| Earnings from Continuing Operations | 46.77% | -30.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.77% | -30.98% | |||
| EBIT | 24.32% | -25.09% | |||
| EBITDA | 19.38% | -20.61% | |||
| EPS Basic | 47.38% | -30.79% | |||
| Normalized Basic EPS | 24.48% | -23.95% | |||
| EPS Diluted | 47.97% | -31.02% | |||
| Normalized Diluted EPS | 24.81% | -23.84% | |||
| Average Basic Shares Outstanding | -0.41% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.68% | -0.41% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.32% | 0.44% | |||